Vienna, VA

Advanced Pediatrics

Human Influenza

Respiratory Syncytial Virus Infections

Communicable Diseases

Pharyngitis

Streptococcal Infections

Infections

Virus Diseases

Hypersensitivity

Paramyxoviridae Infections

Meningococcal Infections

Levalbuterol Tartrate HFA

Modafinil

MedImmune

Quidel

IQuum

Nestlé

Pfizer

Aardvark Medical

Abbott

Cephalon

Gilead Sciences

Luminex

condition

allSponsorName

LumiraDx

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx Influenza A/B + RSV Test at Point of Care Testing Sites

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

Advanced Pediatrics | Vienna, VA

Site insights

Work at this site?

Active trials

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites (INSPIRE)

Trial sponsors